Novel pharmacologic treatment in acute binge eating disorder – role of lisdexamfetamine
Anna I Guerdjikova,1,2 Nicole Mori,1,2 Leah S Casuto,1,2 Susan L McElroy1,2 1Lindner Center of HOPE, Mason, OH, USA; 2Department of Psychiatry and Behavioral Neuroscience, University of Cincinnati College of Medicine, Cincinnati, OH, USA Abstract: Binge eating disorder (BED) is the most common eat...
Guardado en:
Autores principales: | Guerdjikova AI, Mori N, Casuto LS, McElroy SL |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/928e8fc953654f57973a941040c786e4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Relationships between clinical scales and binge eating days in adults with moderate to severe binge eating disorder in two Phase III studies
por: Citrome L, et al.
Publicado: (2018) -
Lisdexamfetamine in the treatment of moderate-to-severe binge eating disorder in adults: systematic review and exploratory meta-analysis of publicly available placebo-controlled, randomized clinical trials
por: Fornaro M, et al.
Publicado: (2016) -
Binge Eating Disorder in Patients with Type 2 Diabetes: Diagnostic and Management Challenges
por: Chevinsky JD, et al.
Publicado: (2020) -
Impact of Bariatric Surgery on the Healthy Eating Index, Binge Eating Behavior and Food Craving in a Middle Eastern Population: A Lebanese Experience
por: Jana Jabbour, et al.
Publicado: (2021) -
Binge eating in patients with polycystic ovary syndrome: prevalence, causes, and management strategies
por: Krug I, et al.
Publicado: (2019)